AI for Science: AI-Driven Drug Discovery with BioNeMo
About This Webcast
If this page does not automatically enter you into the webinar console 15 minutes prior to start time, please refresh your browser. Discover how the BioNemo Agent Toolkit equips researchers and engineers with production-ready AI skills for two of the most impactful challenges in structural biology. In this session, we'll walk through how to deploy state-of-the-art models for protein structure prediction and demonstrate how generative AI can design high-affinity protein binders, improving the quality of drug candidates. Whether you're new to AI-driven drug discovery or scaling an existing pipeline, this session bridges cutting-edge research with practical application. (C) NVIDIA Corporation 2026. All rights reserved. No recording of this webinar should be made or reposted without the express written consent of NVIDIA Corporation.
Speakers
Christian Dallago
Strategic Applied Research Team Lead, , NVIDIA
Jennifer Fleming
PDBe Coordinator , EMBL-EBI
Jennifer is the PDBe Coordinator at EMBL-EBI, with a remit spanning the Protein Data Bank in Europe (PDBe), PDBe-KB and the AlphaFold Protein Structure Database. She trained as an experimental structural biologist, using X-ray crystallography and complementary biophysical techniques to investigate protein structure, interactions and function. Her research later expanded into structural bioinformatics and molecular dynamics simulations, applying sequence and structure comparisons to study relationships across large and diverse protein families. She now brings these experimental and computational perspectives to the development of biological data resources, working with international partners and scientific communities to make experimental and predicted protein structures openly available, interconnected and easier to discover, interpret and reuse.